Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001638599-17-000626

COO and SVP, R*D sold 20,512 shares at $17.00 ($348,640)

  • COO and SVP, R*D acquired 20,512 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Johnston Lloyd P. · COO and SVP, R*D

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-06-15 Exercise or conversion : show line 1 in the form +20,512 $0.47 $9,641 22,118 D
2017-06-15 Sale : show line 2 in the form −20,512 $17.00 $348,640 1,606 D
Open-market sales · 20,512 sh · avg $17.00 · $348,640

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-06-15 Exercise or conversion : show line 3 in the form Employee Stock Option (right to buy) −20,512 $0.47 2019-07-23 20,512 0 D
Loading xslF345X03/doc4_4803.xml…